Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

CARMN fusions and PDGFRB mutations highlight key differences among cutaneous tumors with myopericytic differentiation.

The Journal of investigative dermatology·2026

Same author

CRTC1::TRIM11 Cutaneous Tumors With Atypia: Melanoma Mimicry, Aggressive Potential, and Methylation Classifier Limitations.

Genes, chromosomes & cancer·2026

Same author

STAT6 mutational status and expression in primary mediastinal large B-cell lymphoma.

Pathology·2026

Same author

Rare Secondary Neoplasms Arising in Epidermal Nevus: A Case Series and Literature Review.

Journal of cutaneous pathology·2026

Same author

Spitz Melanocytoma With a Novel CPEB2::MAP3K2 Rearrangement: A Case Report.

Journal of cutaneous pathology·2026

Same author

More Than Skin Deep: Histopathologic Assessment of Tattoo Ink Deposition in Lymph Nodes.

International journal of surgical pathology·2026

Search research articles

Related Experiment Video

Updated: Jul 17, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

CD4+ CD56+ hematodermic neoplasm.

Thomas L Cibull¹, Antoinette B Thomas, Dennis P O'Malley

¹Department of Pathology, Indiana University, Indianapolis, IN 46202, USA.

The American Journal of Dermatopathology

|February 8, 2007

Summary

A rare cutaneous CD4+CD56+ hematodermic neoplasm was identified in a 75-year-old man. This diagnosis is critical for cutaneous hematologic malignancies due to its poor prognosis.

More Related Videos

Murine Model of CD40-activation of B cells

Murine Model of CD40-activation of B cells

Published on: March 5, 2010

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Published on: March 1, 2020

Related Experiment Videos

Last Updated: Jul 17, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Murine Model of CD40-activation of B cells

Murine Model of CD40-activation of B cells

Published on: March 5, 2010

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Published on: March 1, 2020

Area of Science:

Dermatology
Hematology
Oncology

Background:

Cutaneous hematologic malignancies represent a diverse group of neoplasms affecting the skin.
Hematodermic neoplasms are a specific subtype, often presenting as skin lesions.
The CD4+CD56+ immunophenotype defines a rare and aggressive subset of these neoplasms.

Observation:

A case study involving a 75-year-old male patient presenting with a cutaneous neoplasm.
The neoplasm exhibited the specific CD4+CD56+ immunophenotype.
Clinical presentation was characterized by cutaneous lesions.

Findings:

The patient was diagnosed with a CD4+CD56+ hematodermic neoplasm.
This specific neoplasm is characterized by its rarity.
The diagnosis was established through analysis of cutaneous lesions.

Implications:

Accurate diagnosis of CD4+CD56+ hematodermic neoplasms is crucial for patient management.
This diagnosis holds significant importance in the differential diagnosis of skin-based hematologic cancers.
The extremely poor prognosis associated with this condition necessitates prompt and effective therapeutic strategies.